Losartan (2021-08-27) Aug 27, 2021 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type I
Losartan
Lot or serial number Companies Brand name DIN, NPN, DIN-HIM Dosage form Strength 1010419, 1020419 Recalling Firm Sivem Pharmaceuticals ULC 4705 Dobrin Street St. Laurent H4R 2P7 Quebec CANADA Marketing Authorization Holder Sivem Pharmaceuticals ULC 4705 Dobrin Street St. Laurent H4R 2P7 Quebec CANADA Losartan DIN 02388804 Tablet Losartan Potassium 50mg
Presence of impurity (5-[4'-[(5-(Azidomethyl)-2-butyl-4-chloro-1H-imidazol-1-yl) methyl]-[1,1'-biphenyl]-2-yl]-1H-tetrazole) above the acceptable concentration limit in affected lots.